Scientists at St. Jude Children’s Research Hospital have discovered non-coding genetic variants contributing to chemotherapy resistance...

Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to...

By characterizing B-cells’ developmental stages, scientists at St. Jude Children’s Research Hospital designed and tested a drug...

Children experience symptoms of fatigue for at least 2 years following for acute lymphoblastic leukemia (ALL), according to a new study,...

Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with...

Acute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in...

About 15 percent of patients with ALL will relapse, while 30 to 50 percent of patients with AML will have a recurrence, says Melissa...

Childhood B cell acute lymphoblastic leukemia (B-ALL), a type of cancer that affects blood and bone marrow, has historically been a...

New therapies have dramatically improved survival rates among children with pediatric acute myeloid leukemia (pAML)—a cancer that starts...

Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the...